Search Results - Muhammad K. Javaid
- Showing 1 - 9 results of 9
-
1
-
2
Protocol of a randomised trial of teriparatide followed by zoledronic acid to reduce fracture risk in adults with osteogenesis imperfecta by Jennifer Walsh, Catriona Keerie, Stuart H Ralston, Christopher J Weir, Muhammad K Javaid, WAYNE LAM, Bente L Langdahl, Jannie D Hald, Patricia Osborne
Published in BMJ Open (2023-11-01)Get full text
Article -
3
Patients’ recovery of mobility and return to original residence after hip fracture are associated with multiple modifiable components of hospital service organisation: the REDUCE r... by Rita Patel, Andrew Judge, Antony Johansen, Elsa M. R. Marques, Tim Chesser, Xavier L. Griffin, Muhammad K. Javaid, REDUCE Study Group, Yoav Ben-Shlomo, Celia L. Gregson
Published in BMC Geriatrics (2023-07-01)Get full text
Article -
4
Exercise or manual physiotherapy compared with a single session of physiotherapy for osteoporotic vertebral fracture: three-arm PROVE RCT by Karen L Barker, Meredith Newman, Nigel Stallard, Jose Leal, Catherine Minns Lowe, Muhammad K Javaid, Angela Noufaily, Anish Adhikari, Tamsin Hughes, David J Smith, Varsha Gandhi, Cyrus Cooper, Sarah E Lamb
Published in Health Technology Assessment (2019-08-01)Get full text
Article -
5
Assessing a 12-month course of oral alendronate for adults with avascular necrosis of the hip: MANTIS RCT with internal pilot by Sion Glyn-Jones, Muhammad K Javaid, David Beard, Julia Newton, Robert Kerslake, Callum McBryde, Tim Board, Susan J Dutton, Melina Dritsaki, Vikas Khanduja, Magbor Akanni, Shaun Sexton, John Skinner, Nicholas Peckham, Ruth Knight, Ines Rombach, Loretta Davies, Vicki Barber
Published in Health Technology Assessment (2022-10-01)Get full text
Article -
6
REducing unwarranted variation in the Delivery of high qUality hip fraCture services in England and Wales (REDUCE): protocol for a mixed-methods study by Rita Patel, Elsa M R Marques, Yoav Ben-Shlomo, Andrew Judge, Sarah Drew, Rachael Gooberman-Hill, Xavier L Griffin, Tim Jones, Katie Whale, Antony Johansen, Estela Capelas Barbosa, Tim Chesser, Muhammad K Javaid, Celia L Gregson, Jill Griffin, Marianne Bradshaw
Published in BMJ Open (2021-05-01)Get full text
Article -
7
Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment by Karine Briot, Wei Sun, Rachel K Crowley, Maria Luisa Brandi, Stuart H Ralston, Peter Kamenický, Martine Cohen-Solal, Richard Keen, Angela Williams, Muhammad K Javaid, Robin H Lachmann, Annabel Nixon, Mark Nixon, Anne-Lise Lecoq, Sami Kolta, Jennifer S Walsh, Angela J Rylands
Published in RMD Open (2023-02-01)Get full text
Article -
8
Longitudinal dynamics and clinically available predictors of poor response to COVID-19 vaccination in multiple myeloma by Gaurav Agarwal, Sally Moore, Ross Sadler, Sherin Varghese, Alison Turner, Lucia Y Chen, Jemma Larham, Nathanael Gray, Oluremi Carty, Joe Barrett, Constantinos Koshiaris, Jaimal Kothari, Stella Bowcock, Udo Oppermann, Vicky Gamble, Gordon Cook, Chara Kyriakou, Mark Drayson, Supratik Basu, Sarah McDonald, Shelagh McKinley, Sarah Gooding, Muhammad K Javaid, Karthik Ramasamy
Published in Haematologica (2024-01-01)Get full text
Article -
9
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension by Karine Briot, Rachel K Crowley, Maria Luisa Brandi, Stuart H Ralston, Han-Wook Yoo, Peter Kamenický, Takuo Kubota, Nobuaki Ito, Martine Cohen-Solal, Richard Keen, Angela Williams, Muhammad K Javaid, Hiroyuki Tanaka, Robin H Lachmann, Karl Insogna, Richard Eastell, Yasuhiro Takeuchi, Anthony A Portale, Thomas O Carpenter, Hae Ii Cheong, Yasuo Imanishi, Steven Ing, Suzanne Jan de Beur, Farzana Perwad, Pisit Pitukcheewanont, Thomas J Weber, Annabel Nixon, Mark Nixon, Erik A Imel
Published in RMD Open (2021-11-01)Get full text
Article